Health: Cardiology News

Today is March 19, 2024. All times in Eastern Daylight Time.

BeiGene、化学療法後の進行性または転移性食道扁平上皮癌の治療のためのTEVIMBRA®のFDA承認取得

03/16/2024 - 11:18 AM

BUSINESS WIRE
百濟神州喜獲FDA批准，TEVIMBRA®將用於晚期或轉移性食管鱗狀細胞癌在化療後的治療

03/15/2024 - 05:13 PM

BUSINESS WIRE
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03/15/2024 - 04:15 PM

BUSINESS WIRE
BeiGene recebe aprovação da FDA para TEVIMBRA® para tratamento de câncer espinocelular de esôfago avançado ou metastático após quimioterapia prévia

03/15/2024 - 04:02 PM

BUSINESS WIRE
BeiGene reçoit l'approbation de la FDA pour TEVIMBRA® dans le traitement du carcinome épidermoïde de l’œsophage avancé ou métastatique après une chimiothérapie

03/15/2024 - 04:02 PM

BUSINESS WIRE
BeiGene recibe la aprobación de la FDA para TEVIMBRA ® para el tratamiento del carcinoma esofágico de células escamosas avanzado o metastásico luego de una quimioterapia previa

03/15/2024 - 10:41 AM

BUSINESS WIRE
Global Cardiology Medical Imaging Informatics Market - Growth Opportunities in Multimodality Cardiac Imaging for Diagnostic Accuracy and AI-based Cardiology Image Reconstruction and Interpretation - ResearchAndMarkets.com

03/15/2024 - 07:29 AM

BUSINESS WIRE
BeiGene erhält FDA-Zulassung für TEVIMBRA ® zur Behandlung des fortgeschrittenen oder metastasierten Plattenepithelkarzinoms der Speiseröhre nach vorheriger Chemotherapie

03/15/2024 - 02:06 AM

BUSINESS WIRE
Riassunto: BeiGene riceve l’autorizzazione da parte della FDA all’uso di TEVIMBRA® per il trattamento del carcinoma esofageo a cellule squamose metastatico o avanzato successivo alla chemioterapia

03/15/2024 - 02:00 AM

BUSINESS WIRE
Samenvatting: BeiGene ontvangt FDA-goedkeuring voor TEVIMBRA ®voor de behandeling van gevorderd of gemetastaseerd plaveiselcelcarcinoom van de slokdarm na eerdere chemotherapie

03/14/2024 - 07:20 PM

BUSINESS WIRE
BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy

03/14/2024 - 04:28 PM

BUSINESS WIRE
マックス財団、ベイジーン、ベイジーン財団の協力により、低・中所得国の慢性リンパ性白血病患者にBRUKINSA®を初回投与

03/14/2024 - 10:23 AM

BUSINESS WIRE
Vida Health's Obesity Solutions with Integrated Prescribing Capabilities Shows Promising Results

03/14/2024 - 08:54 AM

BUSINESS WIRE
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session

03/14/2024 - 08:31 AM

BUSINESS WIRE
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG

03/14/2024 - 08:31 AM

BUSINESS WIRE
The Max Foundation、BeiGene和BeiGene Foundation共同向中低收入國家的慢性淋巴性白血病病患提供首批BRUKINSA®藥物

03/14/2024 - 05:31 AM

BUSINESS WIRE
Erste Dosen von BRUKINSA ® für Patienten mit chronischer lymphatischer Leukämie in Ländern mit niedrigem und mittlerem Einkommen im Rahmen der Zusammenarbeit von The Max Foundation, BeiGene und der BeiGene Foundation

03/13/2024 - 03:01 PM

BUSINESS WIRE
Primeras dosis de BRUKINSA® suministradas a pacientes con leucemia linfocítica crónica en países de renta baja y media en colaboración con The Max Foundation, BeiGene y BeiGene Foundation

03/13/2024 - 03:01 PM

BUSINESS WIRE
Les premières doses de BRUKINSA® sont administrées à des patients atteints de leucémie lymphoïde chronique dans des pays à revenus faibles et moyens, grâce à la collaboration de la Max Foundation, de BeiGene et de la BeiGene Foundation

03/13/2024 - 03:01 PM

BUSINESS WIRE
Samenvatting: Eerste dosissen BRUKINSA® verstrekt aan patiënten met chronische lymfatische leukemie in lage- en middeninkomenslanden in samenwerking met The Max Foundation, BeiGene en de BeiGene Foundation

03/13/2024 - 01:51 PM

BUSINESS WIRE
Riassunto: Prime dosi di BRUKINSA ® somministrate a pazienti affetti da leucemia linfatica cronica in paesi a basso e a medio reddito grazie alla collaborazione tra The Max Foundation, BeiGene e la fondazione BeiGene

03/13/2024 - 01:51 PM

BUSINESS WIRE
As primeiras doses de BRUKINSA® fornecidas a pacientes com leucemia linfocítica crônica em países de baixa e média renda sob a colaboração da The Max Foundation, BeiGene e BeiGene Foundation

03/13/2024 - 01:50 PM

BUSINESS WIRE
Zephyr AI Raises $111 Million in Series A Financing

03/13/2024 - 01:28 PM

BUSINESS WIRE
Life Guard Imaging Celebrates Patient Cindy Withers Throwing Ceremonial First Pitch at New York Yankees Spring Training Game

03/13/2024 - 12:51 PM

BUSINESS WIRE
BioSkryb Launches New Whole Genome and Transcriptome Core Kits to Accelerate Single-Cell Multiomics

03/13/2024 - 09:00 AM

BUSINESS WIRE

1 2 3 4 5

Next »

Search